Try GOLD - Free
Chargebee boosts India focus
Mint New Delhi
|July 11, 2025
Chargebee is valued at $3.5 bn after a $250 mn Series H round in 2022, co-led by Tiger Global and Sequoia
Subscription and recurring billing management platform Chargebee is increasing its focus on India, as more multinational companies look to the country as a source of revenue.
"India is an important market for two parts: One, our customers to collect money from here. Second, India as a market is growing, especially with the number of companies which are able to list here," said Chargebee co-founder and chief executive Krish Subramanian.
At its core, Chargebee helps businesses automate subscriptions, from helping companies figure out the best pricing models for their services to recognising sources of revenue, collections, and customer retention.
Chargebee is currently valued at $3.5 billion after a $250 million Series H round in 2022 co-led by Tiger Global and Sequoia Capital.
This story is from the July 11, 2025 edition of Mint New Delhi.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint New Delhi
Mint New Delhi
India's AI push gets $15 bn Google boost
Move raises Big Tech's total India AI investment plan to $25 bn
2 mins
October 15, 2025
Mint New Delhi
Fresh GST tweaks to wait as govt scans reforms' execution
Central and state governments will retain the current framework of the indirect tax system and maintain the existing goods and services (GST) tax rates as they assess the impact of recent reforms on revenue collection growth before introducing further rate revisions or structural changes such as subsuming petroleum products, according to two people aware of internal discussions.
2 mins
October 15, 2025
Mint New Delhi
Why were sugar exports not so sweet this year?
In January, the central government allowed sugar exports totalling I million tonnes for the 2024-25 season (October-September). However, their shipments fell short of the allotted quota. What went wrong? Mint explains.
2 mins
October 15, 2025
Mint New Delhi
Bira's backers discuss fund infusion tied to CEO's exit
Some large institutional stakeholders in B9 Beverages, maker of Bira 91 beer, have started discussions on the removal of founder and chief executive officer (CEO) Ankur Jain citing his inability to run the financially troubled company, four people aware of the development said.
3 mins
October 15, 2025
Mint New Delhi
Morgan Stanley, MUFG start $1 bn Vena India sale process
GIP to fully exit Vena Energy India as global capital flows into India’s clean energy market
2 mins
October 15, 2025
Mint New Delhi
India needs $217 bn for its nuclear goal
India will require nearly ₹19.3 trillion ($217 billion) of investment to reach its target of installing 100 gigawatts of nuclear power capacity by 2047, according to a power ministry panel’s report, published Tuesday.
1 min
October 15, 2025
Mint New Delhi
How Taylor Swift rewrote the business of record sales
For almost a decade, Adele’s 25 has held the record for first-week album sales with nearly 3.5 million. That mark appeared insurmountable until Taylor Swift released The Life of a Showgirl on Oct. 3. The pop star blew past Adele's total in five days, ultimately earning a hair more than 4-million sales.
4 mins
October 15, 2025
Mint New Delhi
TV old guards bet on short-video boom
As TV suffers a slow decline and audiences rush to dopamine-fuelled shortspan entertainment, makers of hit soap operas that dominated Indian entertainment are turning to microdramas and other short video and audio formats.
2 mins
October 15, 2025
Mint New Delhi
How innovation sustains growth: Mokyr richly deserves his Nobel
Knowledge absorption holds the key and that could depend on a society's openness to ideas and readiness to embrace change
4 mins
October 15, 2025
Mint New Delhi
Roche moves SC against Natco over Risdiplam sale in India
Swiss drugmaker Roche has moved the Supreme Court, seeking to restrain Natco Pharma from selling the generic version of its lifesaving spinal muscular atrophy (SMA) drug Risdiplam in India.
1 mins
October 15, 2025
Listen
Translate
Change font size